Monistat-1 Vag Oint 6.5%


Indications and Reactions:

Role Indications Reactions
Primary
Vulvovaginal Mycotic Infection 92.2%
Contraception 5.2%
Bipolar Disorder 0.4%
Fungal Infection 0.4%
Hypertension 0.4%
Migraine 0.4%
Muscle Spasms 0.4%
Seasonal Allergy 0.4%
Staphylococcal Infection 0.4%
Vaginal Swelling 21.8%
Vulval Oedema 18.2%
Drug Ineffective 17.6%
Vaginal Burning Sensation 13.2%
Vulvovaginal Discomfort 7.8%
Vaginal Discharge 6.0%
Abdominal Pain 3.2%
Vaginal Pain 2.8%
Oedema Genital 1.6%
Vaginal Haemorrhage 1.6%
Genital Pruritus Female 1.2%
Hypersensitivity 0.8%
Penile Discharge 0.8%
Vaginal Oedema 0.8%
Abdominal Discomfort 0.4%
Genital Burning Sensation 0.4%
Pain 0.4%
Poor Quality Drug Administered 0.4%
Rash Pruritic 0.4%
Urticaria 0.4%
Secondary
Vulvovaginal Mycotic Infection 100.0%
Vulvovaginal Discomfort 100.0%
Concomitant
Vulvovaginal Mycotic Infection 100.0%
Vulvovaginal Discomfort 100.0%

Drug Data